US Patent

US10335451 — Method of treating low blood pressure

Method of Use · Assigned to George Washington University · Expires 2029-12-16 · 4y remaining

Vulnerability score 59/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a method of treating patients with septic shock, acute kidney injury, severe hypotension, cardiac arrest, or refractory hypotension using Angiotensin II.

USPTO Abstract

A method for treating a patient suffering from one of septic shock, acute kidney injury, severe hypotension, cardiac arrest, and refractory hypotension, but not from myocardial infarction, is provided. The method includes administering a therapeutically effective dose of Angiotensin II, or Ang II, to the patient.

Drugs covered by this patent

angiotensin-ii-acetate (ANGIOTENSIN II ACETATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2581`	—	angiotensin-ii-acetate
`U-2581`	—	angiotensin-ii-acetate
`U-2581`	—	angiotensin-ii-acetate

Patent Metadata

Patent number: US10335451
Jurisdiction: US
Classification: Method of Use
Expires: 2029-12-16
Drug substance claim: No
Drug product claim: No
Assignee: George Washington University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.